The Enterprise Value as of December 2025 (TTM) for OncoTherapy Science, Inc. (4564.T) is 5.92B

According to OncoTherapy Science, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.92B. This represents a change of -19.28% compared to the average of 7.33B of the last 4 quarters.

OncoTherapy Science, Inc. (4564.T) Historical Enterprise Value (quarterly & annually)

How has 4564.T Enterprise Value performed in the past?

The mean historical Enterprise Value of OncoTherapy Science, Inc. over the last ten years is 15.30B. The current 5.92B Enterprise Value has changed 3.77% with respect to the historical average. Over the past ten years (40 quarters), 4564.T's Enterprise Value was at its highest in in the June 2017 quarter at 35.07B. The Enterprise Value was at its lowest in in the March 2024 quarter at 3.93B.

OncoTherapy Science, Inc. (4564.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OncoTherapy Science, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OncoTherapy Science, Inc. (4564.T) Average Enterprise Value

How has 4564.T Enterprise Value performed in the past?

The current Enterprise Value of OncoTherapy Science, Inc. (4564.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

OncoTherapy Science, Inc. (4564.T) Enterprise Value vs. Peers

How is 4564.T’s Enterprise Value compared to its peers?

OncoTherapy Science, Inc.’s Enterprise Value is greater than K Pharma,Inc. (5.59B), greater than BrightPath Biotherapeutics Co., Ltd. (3.72B), less than ADR120S, Inc. (7.07B), greater than Noile-Immune Biotech Inc. (2.66B), greater than TMS Co., Ltd. (2.91B), greater than Linical Co., Ltd. (3.51B), less than Chiome Bioscience Inc. (6.34B), greater than MedRx Co., Ltd (4.86B), less than Kohjin Bio Co., Ltd. (6.85B), greater than Delta-Fly Pharma, Inc. (5.18B),

Build a custom stock screener for OncoTherapy Science, Inc. (4564.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoTherapy Science, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoTherapy Science, Inc. (4564.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoTherapy Science, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.